Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$0.1487
−$0.1948 · -56.71%
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Previous close
$0.1487
−$0.1948 · -56.71%
Regular session · ET · Market data may be delayed.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Day range
Current $0.1487
52-week range
Current $0.1487
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
62
Undervalued
Sentiment
57
Mixed
Risk
79
High Risk
Momentum
35
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Day range
Current $0.1487
52-week range
Current $0.1487
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.07M USD | 1.74M USD | 1.93M USD | 1.97M USD | 2.6M USD |
| Cost of goods sold | 889.35K USD | 1.37M USD | 1.37M USD | 1.55M USD | 1.35M USD |
| Gross profit | 183.28K USD | 367.43K USD | 553.97K USD | 426.27K USD | 1.25M USD |
| Research and development | 178.77K USD | 191.39K USD | 184.19K USD | — | — |
| Selling, general, and administrative | 7.13M USD | 3.05M USD | 3.07M USD | 6.03M USD | 6.44M USD |
| Operating expenses | 7.31M USD | 3.05M USD | 3.07M USD | 6.03M USD | 6.44M USD |
| Interest expense | 62.97K USD | 648.22K USD | 544.28K USD | 476.78K USD | 36.7K USD |
| Depreciation and amortization | 143.22K USD | 82.3K USD | 203.25K USD | 250.16K USD | 320.01K USD |
| Operating income | −7.12M USD | −2.68M USD | −2.52M USD | −5.61M USD | −5.19M USD |
| Net income | −6.21M USD | −3.3M USD | −3.1M USD | −5.93M USD | −5.74M USD |
Company facts updated Oct 11, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 10, 2026 | 1:80 | — | — |
Stock split | Feb 3, 2026 | 1:150 | — | — |
Stock split | Feb 25, 2025 | 1:8 | — | — |
Stock split | Oct 5, 2023 | 1:25 | — | — |
Stock split | May 19, 2022 | 1:20 | — | — |
Stock split | Feb 22, 2021 | 1:4 | — | — |
Effective Aug 10, 2026
1:80
Effective Feb 3, 2026
1:150
Effective Feb 25, 2025
1:8
Effective Oct 5, 2023
1:25
Effective May 19, 2022
1:20
Effective Feb 22, 2021
1:4
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
